InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the complete record of transactions filed by Kim Julie So-Young. Officer active across 1 company, notably TAKEDA PHARMACEUTICAL CO LTD. Cumulatively, 4 filings have been published. Split: 0 buy · 1 sell. Total volume traded: €1.3m. History available since 27 April 2026. The latest transaction was disclosed on 10 August 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations